Search results
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena via Yahoo Finance· 1 day agoVerastem gained an exclusive wordwide licence for avutometinib from Chugai Pharmaceuticals in...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 23 hours agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 1 day agoWhile these three stocks gained notoriety back in 2020 during the COVID-19 pandemic, it appears this week's detection of avian bird flu in a second...of...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 5 days agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 2 days agoThis month, the company announced it was pulling the vaccine off the market globally, citing a decline in demand. The association between the AstraZeneca COVID-19 vaccine and a rare and dangerous ...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 5 days agoModerna CEO Stéphane Bancel recently told Barron’s that launching the shots in August instead of...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 4 days agoWelford forecasts more than $9 billion in peak sales for datopotamab deruxtecan, which is part of a partnership with Daiichi Sankyo. Executives are...
Arizona researcher publishes study on COVID-19 vaccine and tinnitus
ABC 15 Phoenix· 9 hours agoShaowen Bao, a University of Arizona professor, and Robert Edmonds, a COVID-19 vaccine patient from New Mexico. “It’s very difficult when you have a very sudden event, and you're trying to get ...
Gene Panel Predicts Early HER2+ Breast Cancer Prognosis
Medscape· 5 days agoPatients with early-stage HER2+ breast cancer could soon be offered less intensive treatment based...
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 2 days agoShares in some companies that produce vaccines have seen stock boosts following a small number of...